chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came back at 4pm on the same day of vaccination and had the left arm swelling. I advised the patient to take OTC tylenol and benadryl and call her docter OR go to emergency if worsen symptoms. The day after , patient came back with better symptoms.
Patient is feeling tingling feeling on the left wrist and left wrist is area is slightly red.
swelling in my left injection site arm; very tired for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling in my left injection site arm) and FATIGUE (very tired for 2 days) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031BZIA) for COVID-19 vaccination.     Concomitant products included SPIRONOLACTONE (SPIRONOLACTON) and VITAMINS NOS for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE SWELLING (swelling in my left injection site arm) and FATIGUE (very tired for 2 days). In April 2021, FATIGUE (very tired for 2 days) had resolved. At the time of the report, VACCINATION SITE SWELLING (swelling in my left injection site arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Lab data was not provided Treatment product was not provided by the reporter  This case refers only to the events of the first dose of the Moderna COVID-19 Vaccine.   This case was linked to MOD-2021-341010 (Patient Link).; Sender's Comments: This case concerns a  36-year-old, female patient with no relevant medical history, who experienced the unexpected events of Vaccination site swelling and Fatigue. The events occurred on the day of the first dose of Moderna CoviD-19 Vaccine. The rechallenge was unknown as the events occurred after the first dose and no information about second dose is available. The benefit-risk relationship of Moderna CoviD-19 Vaccine is not affected by this report. This case is downgraded to Non-serious because the events have resolved within 2 days and did not cause hospitalization, permanent disability or incapacity.
can get an awful bad cold.; Initial information was received on 14-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves a male patient who experienced awful bad cold (nasopharyngitis), while he received vaccine INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.   On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE (Produced by unknown manufacturer, lot number and expiration date not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, patient developed a non-serious awful bad cold (nasopharyngitis), (unknown latency) following the administration of INFLUENZA VACCINE. The intensity was severe for the event.  Laboratory data was not reported.   It was not reported if the patients received any corrective treatment or not.  The outcome of the event was unknown at the time of reporting.  There will be no information on the batch number for this case.
During a flu vaccine clinic for employees of at the Treatment Center, this employee was inadvertently given expired influenza vaccine.  The vaccine administered was for the 2021-2022 season and expired on 6/30/2022.  The employee was made aware of the this mistake, did not present with any adverse clinical reaction, and will be administered the influenza vaccine for the 2022-2023 season as soon as clinically appropriate.
arm froze immediately.   patient went to physcian and recommended physical therapy, muscle relaxant, and chiropractic therapy. feeling has just returned in past few days.  patient wasnt upset.
2 hours after the dose today she noticed a bruise at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (2 hours after the dose today she noticed a bruise at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939904) for COVID-19 vaccination.     Previously administered products included for an unreported indication: INFLUENZA VACCINE in October 2021.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Nov-2021, the patient experienced INJECTION SITE BRUISING (2 hours after the dose today she noticed a bruise at the injection site). At the time of the report, INJECTION SITE BRUISING (2 hours after the dose today she noticed a bruise at the injection site) outcome was unknown.            Patient experienced Bruise with flu shot taken a couple of weeks ago and patient also stated she had not taken any treatments.  No concomitant medications were reported.   This case was linked to MOD-2021-372938 (Patient Link).
Patient complaining of about a 3-day history of progressively worsening shortness of breath, difficulty breathing, dyspnea on exertion, decreased energy and appetite, fatigue, and just overall feeling sick.  She started with a dry cough and a little bit of a sore throat on 12/3/21 and was admitted for COVID 19 on 12/6/21 despite being fully vaccinated. Patient is still admitted
QUIETER THAN NORMAL; FEVER; This spontaneous report received from a consumer via a company representative concerned a 37 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included Crohn's disease, and cerebral palsy, non-verbal. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included ustekinumab for Crohn's disease. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced quieter than normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and quieter than normal was not reported. This report was non-serious.
Four days after vaccine: Fever, extreme chills, sore arm, extremely sore throat (could barely swallow), nausea. Symptoms lasted for 12-15 hours then subsided.   Seven days after vaccine: large rash around injection site, subsided within 24 hours.
POLYMYALGIA RHEUMATICA FLARE UP OCCURED APPROX 1 WEEK AFTER 2ND DOSE
Information has been received from a physician concerning a female (age not reported) who on an unspecified date was vaccinated with Gardasil 0.5 ml IM.  The patient fainted after receiving the vaccination.  Unspecified medical attention was sought.  The patient recovered while in the office.  No further information was provided.  Additional information has been requested.
Burning sensation in chest (4/10), redness on face (minor), Patient taken for further monitoring. Vital signs assess and found to be within normal limit upper borderline. After further assessment, patient reports burning feeling subsided. Vital signs: 12:05pm  BP130/90, HR 71 bpm, O2 sat 99%, RR 14, Temperature 96.3 F, lungs sound clear. 12:20pm: BP 129/90, HR 74 bpm, O2 sat 100%, RR 12, Temperature 96.8 F, lung sounds clear.
Suffered allergies; Started to feel an itching in the face/time was passing by the body was itching more and more; Afraid; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Suffered allergies), PRURITUS (Started to feel an itching in the face/time was passing by the body was itching more and more) and FEAR (Afraid) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, HCTZ, LOSARTAN and ALLOPURINOL for an unknown indication.    On 22-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Aug-2021, the patient experienced HYPERSENSITIVITY (Suffered allergies) and PRURITUS (Started to feel an itching in the face/time was passing by the body was itching more and more). 22-Aug-2021, the patient experienced FEAR (Afraid). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in August 2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Suffered allergies), PRURITUS (Started to feel an itching in the face/time was passing by the body was itching more and more) and FEAR (Afraid) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-358758 (Patient Link).
Received Pfizer vaccines on 5/27, 6/18/21 COVID-19 positive by PCR on  1/7/21 admit to hospital on 1/7 d/t suicidal ideation, COVID positive incidentally on admission.
blood clot from Moderna Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clot from Moderna Vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (blood clot from Moderna Vaccine) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (blood clot from Moderna Vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This report was received as the Regulatory Authority.   Concomitant medications were not reported.  Treatment medications were  not reported.  The co- suspect included two doses of Shingles vaccine manufacturer.   The patient got twice vaccinated with the shingles vaccine.  The patient took Moderna COVID-19 vaccine and had a blood clot.  The patient reports they are not kidding about the pain from Shingles.  Company comment: This case concerns a patient of an unknown age and gender, with no reported medical history, but with co-suspect drug Shingles vaccine, who experienced the serious, unexpected AESI event of thrombosis, on unknown date after unspecified dose of mRNA-1273 (Moderna COVID-19 Vaccine). The shingles vaccine may be a confounder to the event.  The event was considered related to the product per the reporter's assessment. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a patient of an unknown age and gender, with no reported medical history, but with co-suspect drug Shingles vaccine, who experienced the serious, unexpected AESI event of thrombosis, on unknown date after unspecified dose of mRNA-1273 (Moderna COVID-19 Vaccine). The shingles vaccine may be a confounder to the event.  The event was considered related to the product per the reporter's assessment. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
Patient is a 68 y.o. male.   Report on admission: patient is a 68 y.o. male presenting from home with c/o  According to patient he has been having dyspnea for past week that got worse since this morning, associated with dry cough, generalized abdominal pain, subjective fever, substernal chest pain.  Patient's wife mentions that he has been declining for past month.  He is not getting out of bed as much.  Patient denies headache, visual disturbances, nausea, vomiting, constipation, dysuria, increased peripheral swelling, focal numbness/weakness.   Hospital course as below.  Cardiology followed patient during stay.  Patient improved with medical treatment.  Patient discharged home in stable condition.  Home health care services arranged, patient declined SNF placement.   1.  COVID, +12/3: -Chest x-ray no pneumonia -Patient requiring oxygen, receiving Decadron remdesivir -Decadron -Remdesivir -Eliquis DVT prophylaxis  2.  Acute hypoxic respiratory failure: -In the setting of above -Wean oxygen as able  3.  New onset A. fib with RVR: -Cardiology following -12/3 echo EF 65%, grade 1 diastolic dysfunction -lopressor dc in setting of bradycardia -Started on Eliquis -30-day event monitor with cardiology  4.  Hypokalemia: -Replace  5.  Generalized weakness: -PT/OT -Social work for discharge needs  6. Obesity
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Patient came in Thursday and showed me her arms.  She received her Pfizer Covid vaccination on Tuesday, 5/18 and noticed her left arm where the vaccination was given was a bit swollen and red a day after.  She came in today for consultation and I recommended her to take some oral Benadryl and offered to call her doctor for her, but she said she is seeing him on Monday.  She will update us on the outcome.
Patient was incorrectly administered Havrix adult dose  (1mL) instead of Havrix pediatric dose (0.5mL) for 2nd Hep A vaccination in series on 3/29/2022. Mother was advised of this adverse event on the same day and advised to monitor for increased risk of local adverse reaction (local tenderness, redness, swelling) at injection site. No adverse effects have been reported by mother since administration at this time.
Chest pain, stiff neck, muscle pain, High blood pressure, headache, nausea, chills, tiredness, exhaustion, dry cough, congestion, severe sinus infection. Lasting 5 weeks after the second Shingles vaccine.  After the 1st dose I experienced tiredness, exhaustion, muscle pain, for 2 weeks.
Patient received 0.5mL for 3rd dose instead of 0.25mL. Patient did not experience any problems.
chest pain in the upper left chest with pain radiating to left arm; Pain experienced is with exercise or exertion, can't do activities without having pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (chest pain in the upper left chest with pain radiating to left arm) and MYALGIA (Pain experienced is with exercise or exertion, can't do activities without having pain) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 027A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MYCOPHENOLATE MOFETIL (MYCOPHENOLATE), TACROLIMUS, PREDNISONE, ASPIRIN [ACETYLSALICYLIC ACID], COLECALCIFEROL (VITAMIN D3), ATORVASTATIN, LOSARTAN and MAGNESIUM OXIDE for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced CHEST PAIN (chest pain in the upper left chest with pain radiating to left arm) and MYALGIA (Pain experienced is with exercise or exertion, can't do activities without having pain). At the time of the report, CHEST PAIN (chest pain in the upper left chest with pain radiating to left arm) and MYALGIA (Pain experienced is with exercise or exertion, can't do activities without having pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Cardiac stress test: inconclusive (Inconclusive) Inconclusive. On an unknown date, Colonoscopy: inconclusive (Inconclusive) Inconclusive. On an unknown date, Endoscopy: inconclusive (Inconclusive) Inconclusive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided.
Pain in arm, concussive feelings, headaches, sensitivity to Light, nausea, chills, feverish
Information has been received from a pharmacist concerning an unspecified number of patients who were vaccinated with a dose of ZOSTAVAX which was stored improperly. The pharmacist did not know the exact temperature the ZOSTAVAX could have been exposed to but stated it could have been elevated when it was dispensed as the temperature was not monitored in their freezer. In addition the ZOSTAVAX was stored in a dormitory style freezer. No adverse reactions reported. It was unknown of the patients sought medical attention. Attempts are being made to obtain identifying information to distinguish the individual patients mentioned in this report. Additional information has been requested.
p/vax pt devel mesothelioma & sustained permanent injury;event considered medically important;
Pt recvd 2 doses Engerix-B 2nd dose 5NOV91 & 3 min later felt hot, nauseous, dizzy, did not feel well & heart started to pound; @ 5min pt started to vomit, hives, felt nervous from vax, exhausted; 7NOV91 seen by MD felt virus or drug rxn;
I received my shots on March 3, 2008. One of the shots was anthrax and I received the usual lump in my shoulder. The shot was given directly into the muscle of the left shoulder. I was told that the lump and annoying ache would go away soon. I have since received my two remaining shots in my right shoulder, more in the back of the triceps, those two shots both had the accompanying lump and some stiffness but both dissipated without incident but the stiffness/aching has returned. I am now five and a half months into my tour and the ache in my left shoulder has not gone away. I have been to the medical clinic twice (Aril 29 and May13) to have them make observations and both times I received inflammation related medicine (Motrin, meloxicon, and toradol). I indicated to the doctor that the ache goes away (probably 90%) during the day with routine usage but during the night, when the shoulder is inactive, the ache comes back full strength resulting in me being woke-up several times a night when I roll around. In the morning the shoulder is very stiff but it usually starts to feel better within a couple hours. I now have the ache in both my shoulders in the morning. I mentioned to the doctor that I played basketball and volleyball and she said the activity would be good. I mentioned about an x-ray but I believe everyone agrees this is a soft tissue problem and not a problem with the rotator cuff. That being said the only way to "see" what may be wrong is an MRI which there isn't one. I have mentioned this to several other persons and they said they had or heard of others with some degree of residual ache. If I take 800-Motrin that will help with the stiffness especially overnight. I have mentioned this to former super and deputy PPMD on multiple occasions and my current supervisor has heard me mention this as well.
Subsequent to receiving vax, the pt was seen by a dermatologist and a diagnosis of erythema multiforme was made. Titers were drawn to rule out any infections or other causes.
This case was reported by a consumer via call center representative and described the occurrence of nausea in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced nausea, vomiting, chills and general body pain. On an unknown date, the outcome of the nausea, vomiting, chills and general body pain were unknown. It was unknown if the reporter considered the nausea, vomiting, chills and general body pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had received SHINGRIX, 3 months ago from the date of reporting. The patient reported the side effects and asked if she could reach the Centers for Disease Control and Prevention and disconnected the call.
Heavy diarrhea; Bloating; Shooting gas pain from stomach; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Heavy diarrhea), ABDOMINAL DISTENSION (Bloating) and FLATULENCE (Shooting gas pain from stomach) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007m20a) for COVID-19 vaccination.     No medical history was reported.  The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN, FINASTERIDE and TAMSULOSIN for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (Heavy diarrhea), ABDOMINAL DISTENSION (Bloating) and FLATULENCE (Shooting gas pain from stomach). At the time of the report, DIARRHOEA (Heavy diarrhea), ABDOMINAL DISTENSION (Bloating) and FLATULENCE (Shooting gas pain from stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt was sitting in observation area after vaccine administation and reported feeling "woozy" to RN at 0920. Pt reported mild nausea and lightheadedness, denies any other sxs. RN requested assistance from site lead and RN sat with Pt for about 5 min and instructed to take slow breathes then walked Pt closer to nurse's station. Pt reported feeling some anxiety but was starting to feel better after sitting near RN. Advised Pt to stay for 30 min observation instead of 15 min and Pt agreed. At 0944 Pt reported all sxs had resolved and ambulated out of building with steady gait in stable condition.
Complained of chills 10 minutes after vaccine administration. EMS checked blood sugar but machine could not read. It was either too low or too high.. BP 219/89, EKG was unremarkable. Patient was advised by EMS and NP to be transported to ER but decline. Preferred to be transported to by the husband  to PCP.
Patient  experienced loss of taste and lack of appetite. Passed away on 1/23/21.
15 minutes after receiving flu vaccine I began to have signs of advancing anaphylactic shock. Breathing became difficult, my larynx spasmed and I was unable to speak, profuse sweating, weakness in limbs, dizzines,inability to walk. Transported by ambulance to Hospital, at 6:00pm. Albuterol inhaler used and 0.3mg Epinephrine autoinject pen. Enroute to the hospital an IV line was started and I received a nebulizer treatment, 50 mg Benadryl orally, and more Epinephrine and then was on oxygen for a total of four hours. Dr. at hospital administered more Benadryl, Prednisone Solumedrol. Laryngeal spasms lessened by 8:30 pm. I was discharged about 9:00 pm with a prescription for 40 mg Prednisone for four days and instruction to take 50 mg of Benadryl once at home.
Administered after the vaccine had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired). On 23-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient received the Moderna Covid-19 vaccine after the vaccine had expired. The patient didn't experience any reported symptoms.  No Concomitant product use was reported. No treatment information was provided.   This case was linked to MOD-2021-413434 (Patient Link).